For the Inventor, By the Inventor

Enter assignee name

Davis, CA, United States of America

Novozymes, Inc.

Calculating rank

USPTO Granted Patents = 384

% Expired Patents = 67.7

CIPO Patents = 9

EPO Patents = 134

Forward Citations = 1,112

Loading Chart...

Loading Chart...

169 inventors (with patents filed for the assignee):

Paul Vincent Harris (68 out of 83 patents)

Debbie Sue Yaver (45 out of 81 patents)

Lan Tang (44 out of 64 patents)

4. Kimberly M Brown (43 out of 67 patents)

5. Ye Liu (42 out of 130 patents)

6. Nikolaj Spodsberg (40 out of 75 patents)

7. Junxin Duan (38 out of 57 patents)

8. Elena Vlasenko (34 out of 39 patents)

9. Yu Zhang (29 out of 428 patents)

10. Michael W Rey (29 out of 63 patents)

11. Feng Xu (28 out of 50 patents)

12. Randall Kramer (26 out of 27 patents)

13. Brett McBrayer (25 out of 35 patents)

14. Tarana Shaghasi (24 out of 26 patents)

15. Michael Lamsa (22 out of 27 patents)

Core Competencies:

Cellulolytic Enzymes

GH61 Variants

Beta-Xylosidase

Endoglucanase

Cellobiohydrolase

Polypeptides

Saccharification

Filamentous Fungi

Trichoderma

Polysaccharide Degradation

Protease-Deficient Mutants

Lignocellulosic Material

384 patents: Sort by Forward Citations

1. 12331332 - GH61 variants and polynucleotides encoding same (2025-06-17),

2. 12234493 - Compositions for saccharification of cellulosic material (2025-02-25),

3. 12195776 - Cellulolytic enzyme compositions and uses thereof (2025-01-14),

4. 11891637 - GH61 polypeptide variants and polynucleotides encoding same (2024-02-06),

5. 11713476 - Compositions for saccharification of cellulosic material (2023-08-01),

6. 11427847 - [object Object] (2022-08-30),

7. 11345905 - GH61 polypeptide variants and polynucleotides encoding same (2022-05-31),

8. 11230723 - Cellulolytic enzyme compositions and uses thereof (2022-01-25),

9. 11208641 - Polypeptides having cellobiohydrolase activity and polynucleotides encoding same (2021-12-28),

10. 11203746 - Polypeptides having cellobiohydrolase activity and polynucleotides encoding same (2021-12-21),

11. 11098290 - Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same (2021-08-24),

12. 11085061 - Compositions comprising a GH61 polypeptide having cellulolytic enhancing activity and a liquor and method of using thereof (2021-08-10),

13. 11078510 - Methods for producing polypeptides in protease-deficient mutants of (2021-08-03),

14. 11078509 - Methods for producing polypeptides in protease-deficient mutants of (2021-08-03),

15. 11078508 - Methods for producing polypeptides in protease-deficient mutants of trichoderma (2021-08-03),

Company Overview

Novozymes, Inc., headquartered in Davis, CA, specializes in the development and production of cellulolytic enzymes, which play a crucial role in the conversion of biomass into fermentable sugars. The company focuses on innovative technologies such as GH61 variants, beta-xylosidase, endoglucanase, and cellobiohydrolase, leveraging the capabilities of filamentous fungi. Their research aims to enhance saccharification processes, contributing to sustainable solutions in various industries, including biofuels and bioproducts.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

384 Patents

#1 in Davis, CA

#259 in California

#1,206 in US

#2,412 in the World

Davis, CA, United States of America

Novozymes, Inc.

Forward Citations = 1,112

169 inventors:

Paul Vincent Harris (68 out of 83 patents)

Debbie Sue Yaver (45 out of 81 patents)

Lan Tang (44 out of 64 patents)

4. Kimberly M Brown (43 out of 67 patents)

5. Ye Liu (42 out of 130 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Novozymes, Inc.. Retrieved from https://idiyas.com/company/novozymes

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…